WRAIR - Diagnostics and Countermeasures Branch (DCB) Support Services
Closed Solicitation Posted
- Solicitation number
- HT942523R0054
- Agency
- Defense Health Agency Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
Notice details come from SAM.gov. Updated .
About this opportunity
This solicitation seeks proposals to provide operational, scientific, medical, technical, and administrative services to support the Walter Reed Army Institute of Research Diagnostics and Countermeasures Branch in executing clinical services, translational research, and development of diagnostic countermeasures for pathogens of interest to the US Military. Proposals are due by July 17, 2023 and will be evaluated based on offerors' experience and capabilities for performing work involving biosafety levels two and three with potential exposure to biohazardous materials and infectious specimens.
There is no set-aside designation. Performance will involve work in biosafety level two and potentially level three laboratories at unstated budget levels. As no incumbent or current contractor is specified, this appears to be an opportunity for qualified offerors across relevant NAICS and PSC codes to compete to support this research in the interest of national security health matters.
Notice text
To provide the operational, scientific, medical, technical, and administrative services necessary to support the Walter Reed Army Institute of Research (WRAIR), Diagnostics and Countermeasures Branch (DCB) in execution of clinical service delivery for US military personnel, and translational/applied research for generation of Knowledge Products and diagnostic countermeasures that inform response to and management of P and E pathogens of US Military and National Security interests. Performance under this contract shall involve work within Biosafety level two (BSL 2) laboratories; and may, in the future, involve work in BSL three (BSL 3) laboratories. Individuals may be exposed to bio-hazardous materials, and infectious human and animal specimens to include blood, sera, plasma, cells, cerebral spinal fluid, tissue, respiratory (nasal pharyngeal, bronchial washings, saliva) and other secretions containing known and unknown pathogens.
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity